Skip to main content
Log in

Expression, purification and characterization of rat angiopoietin-2 in Pichia pastoris

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Angiopoietin-2 (Ang2) is a member of the Ang family. Its potential in clinical use has been highlighted for its important roles in angiogenesis during the individual development and the growth of tumors. Ang2 is difficult to be expressed in E. coli for its unique structure. The expressions of Ang2 in insect cells (Sf9) and Chinese hamster ovary (CHO) cell line have been reported, however, the large-scale production of Ang2 for application is still pendent. In this study, the expression of Ang2 in Pichia pastoris expression system was described for the first time. The cDNA encoding Ang2 was cloned from the rat vascular tissue by RT-PCR, and inserted in the eukaryotic expression vector pPIZαA, and then transformed into P. pastoris KM71H cells. The expression of recombinant rat Ang2 (rrAng2) was induced by methanol and accounted for about 75% of the total secreted proteins. The recombinant protein was subsequently purified by HisTrap FF crude with a purity of 90%. Functional analysis of the purified rrAng2 demonstrated a specific activity in promoting the survival of ECV304 cells and binding to the Tie2 receptor. Preparation of bioactive rrAng2 not only lays the basis for further functional study but also provides a new strategy for soluble and large-scale production of human Ang2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Fiedler U, Krissl T, Koidl S, Weiss C, Koblizek T, Deutsch U, Martiny-Baron G, Marme D, Augustin HG (2003) Angiopoietin-1 and Angiopoietin-2 share the same binding domains in the Tie2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J Biol Chem 278:1721–1727

    Article  CAS  PubMed  Google Scholar 

  2. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994–1998

    Article  CAS  PubMed  Google Scholar 

  3. Lukasz A, Hellpap J, Horn R, Kielstein JT, David S, Haller H, Kümpers P (2008) Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays. Crit Care 12:R94

    Article  PubMed  Google Scholar 

  4. Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S, Mori M (2001) Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 61:2145–2153

    CAS  PubMed  Google Scholar 

  5. Reiss Y, Knedla A, Tal AO, Schmidt MH, Jugold M, Kiessling F, Burger AM, Wolburg H, Deutsch U, Plate KH (2009) Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2. J Pathol 217:571–580

    Article  CAS  PubMed  Google Scholar 

  6. Sie M, Wagemakers M, Molema G, Mooij JJ, de Bont ES, den Dunnen WF (2009) The angiopoietin 1/angiopoietin 2 balance as a prognostic marker in primary glioblastoma multiforme. J Neurosurg 110:147–155

    Article  PubMed  Google Scholar 

  7. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55–60

    Article  CAS  PubMed  Google Scholar 

  8. Hu B, Cheng SY (2009) Angiopoietin-2: development of inhibitors for cancer therapy. Curr Oncol Rep 11:111–116

    Article  CAS  PubMed  Google Scholar 

  9. Kümpers P, Koenecke C, Hecker H, Hellpap J, Horn R, Verhagen W, Buchholz S, Hertenstein B, Krauter J, Eder M, David S, Göhring G, Haller H, Ganser A (2008) Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies. Blood 112:2139–2148

    Article  PubMed  Google Scholar 

  10. Nasarre P, Thomas M, Kruse K, Helfrich I, Wolter V, Deppermann C, Schadendorf D, Thurston G, Fiedler U, Augustin HG (2009) Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth. Cancer Res 69:1324–1333

    Article  CAS  PubMed  Google Scholar 

  11. Perry BN, Govindarajan B, Bhandarkar SS, Knaus UG, Valo M, Sturk C, Carrillo CO, Sohn A, Cerimele F, Dumont D, Losken A, Williams J, Brown LF, Tan X, Ioffe E, Yancopoulos GD, Arbiser JL (2006) Pharmacologic blockade of Angiopoietin-2 is efficacious against model hemangiomas in mice. J Invest Dermatol 126:2316–2322

    Article  CAS  PubMed  Google Scholar 

  12. Sarraf-Yazdi S, Mi J, Moeller BJ, Niu X, White RR, Kontos CD, Sullenger BA, Dewhirst MW, Clary BM (2008) Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer. J Surg Res 146:16–23

    Article  CAS  PubMed  Google Scholar 

  13. Hwang SJ, Choi HH, Kim KT, Hong HJ, Koh GY, Lee GM (2005) Expression and purification of recombinant human angiopoietin-2 produced in Chinese hamster ovary cells. Protein Expr Purif 39:175–183

    Article  CAS  PubMed  Google Scholar 

  14. Hwang SJ, Kim HZ, Koh GY, Lee GM (2007) Expression and purification of recombinant human Angiopoietin-1 produced in Chinese hamster ovary cells. In Vitro Cell Dev Biol Anim 43:162–167

    Article  CAS  PubMed  Google Scholar 

  15. Kim I, Kim JH, Moon SO, Kwak HJ, Kim NG, Koh GY (2000) Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene 19:4549–4552

    Article  CAS  PubMed  Google Scholar 

  16. Kanazawa H, Tochino Y, Asai K (2008) Angiopoietin-2 as a contributing factor of exercise-induced bronchoconstriction in asthmatic patients receiving inhaled corticosteroid therapy. J Allergy Clin Immunol 121:390–395

    Article  CAS  PubMed  Google Scholar 

  17. Post S, Peeters W, Busser E, Lamers D, Sluijter JP, Goumans MJ, de Weger RA, Moll FL, Doevendans PA, Pasterkamp G, Vink A (2008) Balance between Angiopoietin-1 and Angiopoietin-2 is in favor of Angiopoietin-2 in atherosclerotic plaques with high microvessel density. J Vasc Res 45:244–250

    Article  CAS  PubMed  Google Scholar 

  18. Cereghino JL, Cregg JM (2000) Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev 24:45–66

    Article  CAS  PubMed  Google Scholar 

  19. Luo Y, Kong XP, Xu AM, Jin SG, Wu DH (2009) Expression, purication, and functional characterization of recombinant human interleukin-7. Protein Expr Purif 63:1–4

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was financially supported by National Natural Science Foundation of China (No.30672403).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donggang Xu.

Additional information

J. Wang and L. Zhou contributed equally to this work as co-first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, J., Zhou, L., Cai, X. et al. Expression, purification and characterization of rat angiopoietin-2 in Pichia pastoris . Mol Biol Rep 37, 3909–3913 (2010). https://doi.org/10.1007/s11033-010-0047-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-010-0047-9

Keywords

Navigation